← FDA DRUG APPROVALS

FDA ANDA · ANDA062362

ERYTHROMYCIN ESTOLATE

Sponsor: LIFE LABS

APPLICATION
ANDA062362
TYPE
ANDA
ORIGINAL APPROVAL
1982-12-17
LATEST ACTION
1982-12-17
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

ERYTHROMYCIN ESTOLATEDiscontinued
ERYTHROMYCIN ESTOLATE EQ 250MG BASE/5ML · SUSPENSION · ORAL

Approval history

1982-12-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →